CINECA IRIS Institutional Research Information System

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer

DEANDREIS, Desiree';
2015-01-01
2015
ANNALS OF ONCOLOGY
26
6
1223
1229
http://annonc.oxfordjournals.org/
Concomitant combination; Everolimus; Non-small-cell lung cancer; Phase I; Thoracic radiotherapy; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Everolimus; Female; France; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Protein Kinase Inhibitors; Radiotherapy Dosage; Risk Factors; TOR Serine-Threonine Kinases; Time Factors; Treatment Outcome; Vinblastine; Radiotherapy, Conformal; Hematology; Oncology
Deutsch, Eric; Le Péchoux, C.; Faivre, L.; Rivera, S.; Tao, Y.; Pignon, J.-P.; Angokai, M.; Bahleda, R.; Deandreis, D.; Angevin, E.; Hennequin, C.; Besse, B.; Levy, A.; Soria, J.-C.
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1615203
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 43
social impact